Shamburg News · 8-K filed Oct 27, 2026, 8:16 AM EDT

Altimmune Appoints Peter Greenleaf and Alex Howarth to Board; Three Directors to Retire

ALT · Altimmune, Inc.

  • Leadership change
  • Reg FD disclosure
  • Materiality: medium

On October 23, 2026, Altimmune's Board appointed Peter Greenleaf and Alex Howarth as directors effective November 2, 2026, increasing the Board from nine to eleven members. Directors John Gill, Mitchell Sayare and Klaus Schafer notified the Board they will retire and not stand for re-election at the 2027 annual meeting, serving until then. Each new director will receive an initial option grant for 160,000 shares and an annual cash retainer of $40,000. The company issued a press release dated October 27, 2026 announcing the appointments, furnished as Exhibit 99.1.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 5.02, 7.01, 9.01, accession 0001104659-26-118991.

Written from the filing by Shamburg Markets. Figures are as reported by the company.